An enzyme immunoassay (EIA) was developed for detecting antibody to herpes simplex virus, and the results were compared with those of complement fixation, indirect immunofluorescent-antibody, and plaque reduction neutralization tests. Test sera showed very little nonspecific reactivity even at a starting dilution as low as 1:10. EIA results showed excellent correlation with results obtained by the neutralization test, with an average gain in sensitivity of 1.65. EIA proved very useful in detecting current herpes simplex virus infection, and antibody appeared in all cases soon after clinical onset. EIA appears to be a rapid, sensitive, and specific method for routine demonstration of herpes simplex virus antibody in a clinical setting.
Enzyme immunoassays (EIAs) have been introduced as an alternative to radioimmunoassay for the detection of soluble antigens and for titration of antibodies in biological fluids (5, 6) . Since its introduction, EIA has been applied to serodiagnosis of viral diseases in humans (17) . Although results have been encouraging, problems still exist concerning the nature of the support, the antigen, and its fixation.
The classic technique (5) involves passive adsorption of antigen onto a plastic support in an alkaline medium. Prior testing is necessary to select the most satisfactory type and shape of support to be used (2). Even then, quality variations from one lot of plates to another can hamper reproducibility of the test.
Antigen fixation can be improved by covalent binding of antigen to bovine serum albumin with glutaraldehyde (16) . Another approach is simply to fix antigen to the plastic support with formaldehyde (11) . The nature of the antigen employed can influence the reliability of the reaction. Gilman and Docherty (8) emphasized the necessity of using a partially purified herpes simplex antigen. This reduced excessive background activity which rendered interpretation of results impossible. Under these conditions they obtained a good correlation between complement fixation (CF) and EIA results. EIA gave antibody titers 100-to 200-fold higher than those obtained by CF. However, results were not reliable when sera were tested at a starting dilution below 1:256. This high level of nonspecificity makes it difficult to compare EIA with other techniques currently used for serodiagnosis of herpetic infections. Vestergaard et al. (16) used an antigen prepared from rabbit corneas infected with herpes simplex virus type 1 (HSV-1), solubilized in detergent, and subjected to ion-exchange chromatography to recover a glycoprotein fraction. When this antigen was covalently fixed to plastic, background activity was considerably reduced and there was excellent correlation between EIA and plaque reduction neutralization results, with EIA giving an appreciable increase in antibody titer.
Despite the problems indicated above and the lack of standardization which prevents rigorous, overall interpretation of the results, EIA is considered to be a highly sensitive, specific, and easily performed test.
In light of the results obtained by the abovementioned authors, it seemed of interest to test an immunoenzymatic technique for routine serodiagnosis of HSV disease. We used an antigen that was extracted from infected cells in alkaline medium and fixed to a plastic support with formaldehyde. The results of EIA have been correlated with those of other techniques routinely performed in our laboratory: CF, indirect fluorescent-antibody, and plaque reduction neutralization.
MATERIALS AND METHODS
Sera. A total of 164 sera were tested. First, 110 sera from pregnant women aged 18 to 36 years were collected between weeks 12 and 14 of pregnancy. Sera were immediately randomized and dispensed aseptically for independent use in the various serological tests. Care was taken to avoid hemolysis and bacterial 114 VOL. 11, 1980 contamination. The remaining 54 sera were collected from subjects undergoing active herpesvirus infection. Twelve paired sera came from HSV-1-infected individuals (eight gingivostomatitis cases and four meningoencephalitis cases). Six paired sera were from patients undergoing active cytomegalovirus (CMV) infection and nine paired sera were from those with active varicella-zoster (VZV) disease. The causal virus was isolated from the subjects, and CF seroconversions to the homologous antigen were observed. Sera were stored at -20°C before use in HSV EIA.
Cells. MRC-5 (10) human embryonic lung fibroblasts (passages 25 to 29) were used for virus and antigen production. Cells were grown in Eagle basic medium containing 0.5% sodium bicarbonate and 10% fetal calf serum. After HSV infection, cells were maintained in the same medium without serum.
Viruses. The MacIntyre strain of HSV-1 and the MS strain of HSV-2 were obtained from the American Type Culture Collection. Stock suspensions prepared on MRC-5 cells were titrated by plaque assay (13 When the cytopathic effect was complete, the medium was discarded. Cells were washed in Hanks basic salt solution, scraped off the glass, centrifuged at 650 x g for 10 min, suspended in 0.1 M glycine-NaClNaOH buffer (pH 10) (3 ml for the harvest of each bottle), and then sonicated (3 x 1 min) with an AlcatelPons apparatus type 20-200S (tip T 44c, output control 4). After centrifugation at 10,000 rpm for 10 min (30.2 rotor, Beckman Instruments), the antigen (supernatant fluid) was removed and stored at -80°C until used for testing. Control antigen was obtained from uninfected MRC-5 cells treated in the same way.
Antigens were used at optimal concentration as determined by block titration against six human immune sera and six antibody-negative sera (as shown by plaque reduction test). The working dilution was one giving maximum reactivity with immune sera and a negligible reaction with negative sera. For the test, the antigen dilution was 1:400, corresponding to approximately 120 ,ug of protein per ml, as determined by ultraviolet absorption using bovine serum albumin as a standard.
( , and plaque reduction neutralization (C) for 110 sera from asymptomatic, pregnant women. These techniques correlated significantly with EIA, which proved to be from 2-to 16-fold more sensitive.
Thirteen sera were negative (<1:5) by CF. Of these, 11 had neutralizing titers of <1:10, and 9 were negative (<1:10) by indirect fluorescent antibody and EIA. It thus appears that the basic lack of sensitivity of CF may lead to false-negative results (15) . Two sera were positive by EIA although they had titers of <1:10 by neutralization. It is difficult to know whether these sera were truly positive as detected by the increased sensitivity of EIA, or whether EIA titers represent a nonspecific reaction, even though these sera did not react with control antigen (<1:10).
ETA specificity. To test specificity, paired sera from patients with active VZV and CMV infections were tested in the HSV EIA reaction. The paired sera all showed a greater than four- VOL. 11, 1980 fold CF antibody increase to the corresponding VZV or CMV antigen, and in all cases, the causal virus was isolated ( VZV  <5  10  80  80  40  80   11  VZV  <5  5  40  80  20  40  12  VZV  <5  <5  20  160  20  40  13  VZV  <5  5  80  80  20  80  14  VZV  <5  10  80  160  40  80  15  VZV  <5  <5  10  80 10 20 aHSV antibody response in six patients with current CMV infections and nine patients with active VZV infections.
Influence of the plastic support. The 35 sera used above were tested in parallel by the same technician on various types of plates (see Materials and Methods). Results were the same with, at most, a one-dilution difference for flatbottomed plates. When plates treated for tissue culture were used, results were not as reliable due to an increased background level. With round-bottomed plates, reading of wells was irregular due to the design of the spectrophotometer used. However, visual examination was feasible using our enzyme-substrate system, and it yielded valid results.
Storage of sensitized plates. Plates were coated, treated with formaldehyde, and then stored at -20°C. The 35 sera used for reproducibility tests were assayed successively eight times in the course of 1 month by the same technician, each time with a series of stored plates. Results were remarkably consistant, and variations in titers did not exceed a onefold dilution. In 280 assays, the same titers were obtained 148 times, a one-dilution difference was obtained 116 times, and a two-dilution difference was found 16 times. Negative titers (<1:10) were particularly consistent. Eight separate testings of three sera with titers <1:10 resulted in only three weakly positive reactions (1:10).
Reliability of EIA for diagnosis of active HSV infection. (8) , no appreciable background reactivity was detected even at a starting serum dilution as low as 1:10. However, as a measure of security, the initial serum dilution was fixed at 1:20 for future determinations.
The only problems in interpreting the results occurred with sera that were hemolyzed or contaminated with bacteria. The problem of hemolysis was circumvented by careful collection of blood and rapid serum separation. Aseptic handling of sera and the addition of sodium azide resolved the problem of contamination.
EIA correlated well with CF (r = 0.50; P < 0.001) and particularly with plaque reduction neutralization (r = 0.73; P < 0.001), and gave, in the latter case, an average gain in sensitivity of 1.65-fold. EIA also showed an excellent correlation with indirect fluorescent antibody (r = 0.83; P < 0.001), which uses the same methodological principle but a different means of visualization. The advantage of EIA is that it depends on a less subjective mode of interpretation when spectrophotometry is used. In addition, EIA can be read easily and reliably with the naked eye.
Our results are in general agreement with those of Forghani et al. (7), who studied VZV EIA. Few nonspecific reactions were observed with sera of patients with VZV infection, and none was observed with those from CMV-infected individuals. A demonstrable EIA antibody response appeared soon after the clinical onset of active HSV infection. Nevertheless, it was possible to detect a clear seroconversion in all cases. However, it was difficult to determine a possible significant titer in a single serum. It could be suggested that titers of -1:2,560 might indicate a recent infection. J. CLIN. MICROBIOL.
Antigen prepared as described under Materials and Methods could not distinguish between HSV-1 and HSV-2 antibodies. This was expected in light of the strong antigenic relationship between the two serotypes (9, 18) , and the type determination of antibody was not the purpose of this work. Type-specific antibodies should therefore be sought by using a purified antigenic fraction, and this point deserves a further investigation.
It is remarkable that other techniques, and especially CF, yielded a wide range of titers for the same EIA titer, particularly in sera with low and moderate titers. A possible explanation might be that after primary herpesvirus infection residual antibodies are heterogeneous, with variable reactivity among different subjects. Due to its sensitivity, EIA might detect nonavid antibodies more reliably than do other tests. It is also possible that the greater precision and objective interpretation of EIA result in less diversity among titers.
As demonstrated elsewhere, different lots of plates can attach antigen in an irregular manner (3). For this reason, we investigated the fixation of antigen with formaldehyde (11) . This required more time for preparing sensitized plates but also permitted us to use plates of different makes, shapes, and batches, except for plates treated for tissue culture which consistently gave high background reactivity.
In our hands, EIA demonstrated desirable properties for a medical virological laboratory in terms of sensitivity, reproducibility and specificity, ease of performance and adaptability to daily routine work, use of reagents that are easy to prepare or to obtain, and objective reading of results. However, to ensure valid results, it was essential to use correctly collected sera, to carefully pretitrate both antigen and conjugate, and to wash plates thoroughly to avoid background reactivity which interfered with valid reading. Taking these precautions into consideration, we feel that EIA is currently a good routine tool for serodiagnosis of herpetic infections.
